Subscribe to our email list

NCALA Logo

FW: NC DHHS COVID-19 LTC Weekly Update Email – 01/20/2021

LTC Vaccination 101 Webinar – Thursday 1/21/2021 – 10-11am EST

There are two webinars this week.   This webinar will cover general information on vaccines and will leave time for Q&A:

Date & Time: 1/21/2021 Thursday 10:00am – 11:00am

Link to join Webinar

https://zoom.us/j/99794997344

 

Office telephone:

(312) 626-6799  or (646) 558-8656

Webinar ID:  997 9499 7344

 

iPhone one-tap :

+13126266799,,99794997344#

Vaccination Q&A for Long-Term Care Facility Staff  Webinar– Friday 1/22/2021 – 12-1PM EST

This webinar will provide an opportunity for LTC staff to hear from and ask questions to a panel of presenters including LTC staff who have been vaccinated, an obstetrics and gynecology physician as well as COVID-19 health equity champions from NC DHHS to answer questions and share their experiences with you. 

Register for Webinar Here:

https://attendee.gotowebinar.com/register/5400594819888514832

 

 Additional Q&A sessions are being scheduled as well for the coming weeks including session in Spanish.

Education and Information on Vaccines for Staff

In addition to the webinars above, your facility may be contacted by a member of DHHS to hear about any barriers or hesitancy on vaccine among LTC staff.  Please let them know of any questions or concerns you are hearing so we can adjust our efforts! Also please keep in mind the following resources to share with staff:

YouTube

 

CDC has also released a toolkit as a resource for explaining COVID-19 vaccination to both residents and staff in LTCFs. It includes resources for talking with staff, residents, and families, FAQs on the vaccines, and tips on how to prepare staff and vaccine safety monitoring and reporting.   Access it here: https://www.cdc.gov/vaccines/covid-19/toolkits/long-term-care/index.html.

LTC Federal Pharmacy Partnership with CVS/Walgreens Updates

LTC facilities enrolled in the CVS/Walgreens partnership can inform residents who have been discharged upon completion of the first dose of the COVID-19 vaccine that they can return to the facility during the next clinic date for their second dose. CVS and Walgreens teams will provide the second dose of COVID-19 vaccine at the next clinic date. 

LTC Vaccination Provider Enrollment

If your facility or long term care pharmacy wishes to enroll as a COVID-19 vaccine provider go to the CVMS Vaccine Support page and click the Register link at the top right of the page to start the process. Follow this link for CVMS Enrollment Instructions/Training it has a large amount of training information including training videos as well.

As a reminder, COVID-19 vaccine providers must be qualified under the CDC agreement to prescribe COVID-19 vaccines and authorized under the appropriate NC licensing authority. Enrolled COVID-19 vaccine providers must be credentialed/licensed in North Carolina. Please understand that while currently qualified providers are welcome to enroll, requests will be addressed in an order aligned with the prioritization phases and the timeline for approval will vary. The State will continuously reassess enrollment prioritization based on needs.

LTC Infection Prevention Updated Guidance & Reminders

Updated CDC Guidance Considerations for Use of SARS-CoV-2 Antigen Testing in Nursing Homes

 

Until guidance changes, everyone, including those who have received COVID vaccination must:

  • continue to practice all prevention measures (wear masks, maintain 6 feet distance, perform frequent hand hygiene, avoid crowds)
  • follow CDC guidance for quarantine following exposure

 

Facilities should closely monitor the availability of PPE and return to routine use (eliminating extended use and limited reuse) of PPE as soon as supply allows.

Reminder- Facilities conducting antigen testing and reporting all test results via NHSN no longer a need to send secure spreadsheets or faxes to the state or to provide eCATR volume surveys.

LTC Facilities – Staffing Shortages

NC DHHS acknowledges that staffing shortages are a difficult challenge faced by some LTC facilities during their outbreak response.  NC DHHS does NOT recommend allowing positive HCP to work before completing their isolation period.

It is important for the facility to communicate with LHD and local emergency manager as soon as possible if there is potential for unmet staffing needs.   

  • If the mitigation strategies listed below have been unsuccessful in meeting staffing needs the facility may consider allowing positive HCP to work with positive residents prior to completing their isolation period.
    • Contact temporary staffing agencies/nursing pools
    • Contact corporate leadership or other sister facilities for temporary staffing support
    • Contact the local emergency manager and local healthcare coalitions for temporary staffing support
    • Implement plans to allow asymptomatic HCP who have had a high-risk unprotected exposure to SARS-CoV-2 but are not known to be infected to continue to work
    • Implement regional plans to transfer patients with COVID-19 to designated healthcare facilities or alternate care sites
    • If staffing shortages continue despite pursuing the strategies listed above, consider implementing criteria to allow HCP with suspected or confirmed COVID-19 who are well enough and willing to work but have not met all the Return to Work criteria to work with positive residents and must follow all appropriate precautions.
  • Please see NC DHHS’s Emergency Resource Requests and CDC’s Strategies to Mitigate HCP Staffing Shortages documents for additional information

Monoclonal Antibodies for Treatment of COVID-19

The Food and Drug Administration (FDA) has recently given emergency use authorization to two monoclonal antibody drugs for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive test results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kg, and who are at high risk of progressing to severe COVID-19 and/or hospitalization.  These two products, bamlanivimab (manufactured by Eli Lilly) and casirivimab/imdevimab (manufactured by Regeneron), are administered via one-time IV infusion, followed by 1-hour of direct patient observation and are intended to be given in an outpatient setting.  Currently US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR) controls the fair and equitable allocation of these products to State Departments of Health on a weekly basis.  Skilled nursing facilities interested in obtaining access to these medications should reach out to their pharmacy provider.  For more information regarding access to monoclonal antibodies for the treatment of COVID-19 in North Carolina, please contact Tim Davis (tim.davis@dhhs.nc.gov).

 

 
 

Sincerely,
North Carolina Assisted Living Association


NCALA Logo
 
Visit NCALA on Facebook Visit NCALA on LinkedIn

 

Share this email
Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.
This email was sent to .
Continue receiving our emails, add us to your address book.